Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field ...

Canyon Vista Medical Center in Sierra Vista has completed $1.3 million in upgrades to its cardiac catheterization lab, ...

Just in time for Heart Month, Rochester General Hospital is celebrating a major advancement in cardiovascular care with the reopening of a fully renovated and technologically upgraded cardiac ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

People with heart failure often need a test called right heart catheterization, where a tube is inserted into the heart to ...

Shares of Pulse Biosciences shot higher after the company reported positive results from its first-in-human feasibility study for its cardiac catheter system to treat atrial fibrillation, a form of ...

Heart patients in Rochester will soon benefit from a major investment in advanced cardiac care. Rochester General Hospital has reopened a fully renovated cardiac catheterization lab following a $1.5 ...

Every February, Children's of Alabama in Birmingham recognizes the patients and families at its Pediatric and Congenital ...

Scientists hope their findings will potentially spare tens of thousands of future heart patients from undergoing a procedure.

The ongoing feasibility study has treated a total of 165 patients across nine investigators in Europe. The company’s CEO, Paul LaViolette, described the results as "an important milestone" that ...

Irbid, Jan. 25 (Petra) - The new Princess Basma Teaching Hospital on Sunday successfully performed its first cardiac ...

Mercy Fort Smith physicians implanted a newly approved defibrillator with few long-term complications.